Urachal Adenocarcinoma: a Case Report and Review of the Literature.
Bladder carcinomas
Partial cystectomy
Urachal adenocarcinoma
Urachus
Urological surgery
Journal
Indian journal of surgical oncology
ISSN: 0975-7651
Titre abrégé: Indian J Surg Oncol
Pays: India
ID NLM: 101532448
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
18
10
2022
accepted:
16
03
2023
pmc-release:
01
09
2024
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
ppublish
Résumé
Urachal adenocarcinoma is one of the rare and aggressive neoplasms that often presents at an advanced stage and has a poor prognosis. Urachal adenocarcinoma makes up 0.17 to 0.34% of all bladder carcinomas. Patients commonly present with hematuria. Wide local excision of urachal mass with umbilicus and surrounding soft tissue en bloc combined with partial or radical cystectomy and bilateral pelvic lymphadenectomy is considered to be the primary surgical management. However, many publications in literature report that en bloc removal of tumor with umbilicus, entire urachal ligament, and bladder dome alone has long-term survival and disease-free period. Here, we present a case of a 50-year-old post-menopausal female patient with a fungating mass in the umbilical region of size approximately 10 cm in maximum diameter with mucopurulent discharge from the mass. The patient had no history of any hematuria, mucinuria, burning micturition, or any particles in urine. A laparotomy was performed, and tumor mass along with the cuff of the bladder dome was removed as en bloc along with umbilectomy. This case report highlights a rare case of urachal adenocarcinoma with a fungating mass of large size in a female patient which is otherwise more commonly seen in males. A review of published literature is also presented.
Identifiants
pubmed: 37900644
doi: 10.1007/s13193-023-01736-6
pii: 1736
pmc: PMC10611656
doi:
Types de publication
Journal Article
Langues
eng
Pagination
677-681Informations de copyright
© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Déclaration de conflit d'intérêts
Conflict of InterestThe authors declare no competing interests.
Références
J Anat. 1930 Jan;64(Pt 2):170-83
pubmed: 17104266
Urol Case Rep. 2021 Aug 02;39:101797
pubmed: 34401351
J Clin Diagn Res. 2013 May;7(5):911-3
pubmed: 23814741
Cancer. 1955 Jul-Aug;8(4):741-58
pubmed: 13240656
Cancer. 1954 Jan;7(1):119-35
pubmed: 13126906
Can Urol Assoc J. 2020 Mar;14(3):E57-E64
pubmed: 31348743
Cancer. 1991 Apr 15;67(8):2165-72
pubmed: 1706216
J Urol. 1958 Feb;79(2):264-73
pubmed: 13514877
Int J Urol. 2007 Oct;14(10):963-5
pubmed: 17880303
BMJ Case Rep. 2021 Apr 15;14(4):
pubmed: 33858907
J Urol. 1982 Jan;127(1):40-2
pubmed: 7057501
Expert Rev Anticancer Ther. 2006 Dec;6(12):1715-21
pubmed: 17181485
J Cancer Res Ther. 2018 Jun;14(Supplement):S512-S515
pubmed: 29970716
J Cancer Res Ther. 2022 Jan-Mar;18(1):291-293
pubmed: 35381804
Cureus. 2021 Nov 18;13(11):e19705
pubmed: 34934573
J Urol. 2007 Jul;178(1):74-8; discussion 78
pubmed: 17499279
Cancer. 2006 Aug 15;107(4):712-20
pubmed: 16826585
Surg Radiol Anat. 1994;16(2):135-41
pubmed: 7940076
J Urol. 1997 Sep;158(3 Pt 2):1316-8
pubmed: 9258204
Dis Markers. 2018 Mar 12;2018:7308168
pubmed: 29721106
J Urol. 2006 Jun;175(6):2042-7; discussion 2047
pubmed: 16697798
J Urol. 1984 Jan;131(1):1-8
pubmed: 6361280
Urol Clin North Am. 1978 Feb;5(1):195-211
pubmed: 417444
J Urol. 2003 Apr;169(4):1295-8
pubmed: 12629346
Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):820-2
pubmed: 18756985